Andrew Savadelis

Mr. Savadelis is an accomplished finance expert with years of experience leading strategy for commercialization stage companies in the technology and biotech industries. Having served in the COO capacity in both public and private organizations, he brings demonstrated success in finance, operations, M&A, strategic alliance negotiations, has raised debt and equity financings, and has handled private, public and IPO financings in both growth and turnaround companies. Mr. Savadelis has served as COO in several companies, on the audit committee and as a Board member of a public biotech company. In his past role as CFO of AE Polysilicon Corporation, he most recently worked with the Department of Energy to negotiate a $250M loan guarantee, and was responsible for the executing market capitalization by 600% to over $130M for a biotech company. He previously managed a $2.4B cash portfolio and worldwide cash flows for Bristol-Myers Squibb. Mr. Savadelis earned his B.S. in biology from Albright College and his M.B.A from Cornell University.